Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women

References

• Alberti MK, Zimmet P, Shaw J. 2006. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 23:469–480.
   PubMed Web of Science ®Google Scholar
• Alvarez-Aguilar C, Enriquez-Ramirez ML, Figueroa-Nunez B, Gómez-García A, Rodríguez-Ayala E, Morán-Moguel C, Farías-Rodríguez VM, Mino-León D, López-Meza JE. 2007. Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population. Exp Mol Med. 39:327–334.
   PubMed Web of Science ®Google Scholar
• Costa LA, Canani LH, Maia AL, Gross JL. 2002. The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients. Diabetes Care. 25:2365–2366.
   PubMed Web of Science ®Google Scholar
• Crews ED, Williams LS. 1999. Molecular aspects of blood pressure. Hum Biol. 71:475–503.
   PubMed Web of Science ®Google Scholar
• Danková Z, Siváková D, Luptáková L, Blažíček P. 2009. Association of ACE (I/D) polamorphism with metabolic syndrome and hypertension in two ethnic groups in Slovakia. Anthrop Anz. 67:305–316.
   PubMed Web of Science ®Google Scholar
• Das M, Pal S, Ghosh A. 2009. Synergistic effects of ACE (I/D) and ApoE (HhaI) gene polymorphisms among the adult Asian Indians with and without metabolic syndrome. Diabetes Res Clin Pract. 86:58–61.
   Web of Science ®Google Scholar
• Deka R, Durakovic Z, Niu W, Zhang G, Karns R, Smolej-Narancic N, Missoni S, Caric D, Caric T, Rudan D, Salzer B, Chakraborty R, Rudan P. 2012. Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol. 39:46–53.
   PubMed Web of Science ®Google Scholar
• Dekker MJ, Girman C, Rhodes T, Nijpels G, Stehouwer C, Bouter L, Heine R. 2005. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 112:666–673.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome. Lancet. 365:1415–1128.
   PubMed Web of Science ®Google Scholar
• Eshtiaghi R, Esteghamati A, Nakhjavani M. 2010. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 65:262–266.
   PubMed Web of Science ®Google Scholar
• Fiatal S, Szigethy E, Széles G, Tóth R, Ádány R. 2011. Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults. J of Renin Angiotensin Aldosterone. 12:531–538.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502.
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Medalie JH, Herman JB, Neufeld H. 1980. Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis. 33:435–443.
   PubMedGoogle Scholar
• Grundy MS, Cleeman IJ, Daniels RS, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SCJr, Spertus JA, Costa F. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 112:2735–2752.
   PubMed Web of Science ®Google Scholar
• Hixson JE, Vernier TD. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Research. 31:545–548.
   PubMed Web of Science ®Google Scholar
• Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 164:1066–1076.
   PubMed Web of Science ®Google Scholar
• Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. 2005. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke. 36:1212–1217.
   PubMed Web of Science ®Google Scholar
• Kaczmarek M. 2007. The timing of natural menopause in Poland and associated factors. Maturitas. 57:139–153.
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK. 2007. Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev. 6:94–108.
   PubMed Web of Science ®Google Scholar
• Lee GJ, Lee S, Kim JY, Jin KH, Cho MB, Kim JY, Jeong WD, Park JH, Kim UJ. 2009. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. Clin Chim Acta. 408:50–55.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Tsai JC. 2002. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care. 25:1002–1008.
   PubMed Web of Science ®Google Scholar
• Lin S, Tsai D, Hsu S. 2006. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 69:512–516.
   PubMedGoogle Scholar
• LinksHajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL. 2007. SMART Study Group. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart. 93:216–220.
   PubMed Web of Science ®Google Scholar
• Liu WP, Chang YT, Chen DJ. 2010. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabol Clin Exp. 59:802–807.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough A, Natale S, Forlani G, Melchionda N. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50:1844–1844.
   PubMed Web of Science ®Google Scholar
• Milionis HJ, Kostapanos MS, Vakalis K, Theodorou I, Bouba I, Kalaitzidis R, Georgiou I, †Elisaf SM, Siamopouloset CK. 2007. Impact of renin–angiotensin–aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 8:181–189.
   PubMed Web of Science ®Google Scholar
• NCEP ATP III – Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adult 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497..
   Google Scholar
• NHLBI Obesity Education Initiative Expert Panel. 2000. The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity; USA, NIH Publication No. 00-4084. p 80..
   Google Scholar
• Olivieri O, Martinelli N, Bassi A, Trabetti E, Girelli D, Pizzolo F, Friso S, Pignatti FP, Corrocher R. 2007. ApoE ϵ2/ϵ3/ϵ4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin Exp Med. 7:164–172.
   PubMed Web of Science ®Google Scholar
• Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sarı I, Yazıcı M, Keleşet I. 2006. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 19:1055–1062.
   PubMed Web of Science ®Google Scholar
• Pitsavos Ch, Panagiotakos BD, Skoumas J, Papadimitriou L, Stefanadis CH. 2008. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA Study. Angiology. 59:225–341.
   Web of Science ®Google Scholar
• Rigat B, Hubert C, Corvol P, Soubrier F. 1992. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1420:33.
   Google Scholar
• Saito T, Nishise Y, Makino N, Haga H, Ishii R, Okumoto K, Ito J, Watanabe H, Saito K, Takeda H, Togashi H, Kubota I, Daimon M, Kato T, Kawata S. 2009. Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population. Metab Clin Exp. 58:1067–1075.
   PubMed Web of Science ®Google Scholar
• Sima A, Iordan A, Stancu C. 2007. Apolipoprotein E polymorphism – a risk factor for metabolic syndrome. Clin Chem Lab Med. 45:1149–1153.
   PubMed Web of Science ®Google Scholar
• Siváková D, Zacharová M, Gašparovič J, Rašlová K, Wsólová L, Bašistová Z, Blažíček P. 2006. Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. Coll Antropol. 2:387–394.
   Google Scholar
• Steer P, Hulthe J, Millgård J, Sarabi MD, Basu S, Vessby B, Linda L. 2002. Endothelial vasodilatory function is predicted by circulating apolipoprotein B and HDL in healthy humans. Lipids. 37:1135–1140.
   PubMed Web of Science ®Google Scholar
• Suh S, Choi S, Ahn H, Yang H, Kim Y, Sung N. 2009. The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey. Metab Clin Exp. 58:1731–1736.
   PubMed Web of Science ®Google Scholar
• Sui X, Church ST, Meriwether AR, Lobelo F, Blair NS. 2008. Uric acid and development of metabolic syndrome in women and men. Metabol Clin Exp. 57:845–852.
   PubMed Web of Science ®Google Scholar
• Szigethy E, Voko Z, Jermendy G, Nádas J, Paragh G, Blaskó G, Kardos L, Hidvégi T, Horváth A, Ádány R, Széles G. 2007. The epidemiology of metabolic syndrome in the Hungarian adult population. Diab Vasc Dis Res Suppl. 1:S94.
   Google Scholar
• Tao HM, Liu WJ, LaMonte JM, Liu J, Wang L, He Y, Li YX, Wang NL, Ye L. 2011. Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population. Metab Clin Exp. 60:1488–1496.
   PubMed Web of Science ®Google Scholar
• Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. 2001. Renin–angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care. 24:356–361.
   PubMed Web of Science ®Google Scholar
• Walldius G, Junger I. 2004. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Int Med. 255:188–205.
   PubMed Web of Science ®Google Scholar
• WHO. 1996. Research on the Menopause in the 1990s Report of a WHO Scientific Group. WHO Technical Report Series. No. 866. Geneva: World Health Organization (WHO).
   Google Scholar
• WHO. 2008. Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: World Health Organization (WHO).
   Google Scholar
• Yano K, Rhoads G, Kagan A. 1977. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis. 30:171–184.
   PubMedGoogle Scholar
• Zajc-Petranović M, Skarić-Jurić T, Smolej-Narančić N, Tomas Z, Krajačić P, Miličić J, Barbalić M, Tomek-Roksandić S. 2012. Angiotensin-converting enzyme deletion allele is beneficial for the longevity for Europeans. Age. 34:583–595.
   PubMedGoogle Scholar